64 -4 (28/2) 2019 — Nuritdinov O., Yulchiboev M. — TO EVALUATE THE ACTIVITY OF SALIVA ARGINASE IN CHILDREN WITH CHRONIC VIRAL HEPATITIS

TO EVALUATE THE ACTIVITY OF SALIVA ARGINASE IN CHILDREN WITH CHRONIC VIRAL HEPATITIS

Nuritdinov O., Andijan State Medical Institute.

Yulchiboev M. Andijan State Medical Institute.

Resume,

The formation of any pathology is associated with a malfunction of certain organs or metabolic processes. Because everything in the body is interconnected, any failure can affect the operation of the entire system. This relationship and unity is especially pronounced in case of disruption of the digestive system.

Hepatitis is a collective term called pathology that combines liver damage for various reasons and most often has an infectious nature. This disease can form in both children and adults, and in approximate percentage equilibrium.

With hepatitis, not only specific symptoms appear in the oral cavity, all of it – its tissues – become more vulnerable in the face of aggressive factors, the level of protection decreases. The same can be said about the negative impact of dental diseases, whether gum disease or caries, on the course of the underlying pathology.

The frequency of detection of clinical and histological signs of salivary glands in chronic HCV infection ranges from 11 to 77%, which depends on the  level of targeted examination of patients with chronic hepatitis C for the presence of dry syndrome. Morphological changes in the tissue of the salivary glands (SJ) in chronic hepatitis C, called “lymphocytic sialadenitis,» are characterized by lymphoid infiltration, reminiscent of the histological signs of SJ disease. Most researchers consider lymphocytic sialadenitis because of an immunopathological reaction to a chronic viral infection.

Keyword: salivary gland, arginase, hepatitis, viral infection.

First page

241

Last page

243

For citation: Nuritdinov O., Yulchiboev M. To evaluate the activity of saliva arginase in children with chronic viral hepatitis//New Day in Medicine 4(28)2019 241-243 https://cutt.ly/Xbd9n3A

List of References

1. Дунаева Н.В., Эсауленко Е.В. Структурно-функциональная организация генопа вируса гепатита С. Вопросы вирусологии. 2006; 51 (2): С. 10-14.
2. Мукомолов С.Л., Калинина О.В., Ликий И.В. и др. Молеку­лярно-биологическая характеристика возбудителей вирусных гепатитов В и С. Профилактическая и клиническая медицина. 2008; 3: С. 27-30.
3. Yang J.D., Roberts L.R. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010; 7: 448-458.
4. Tateyama M., Yatsuhashi H., Taura N. et al. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. Gastroenterol. 2011; 46: 92-100.
5. Trevisani F., D’Intino P.E., Morselli-Labate A.M. et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti- HCV status. J Hepatol. 2001; 34: 570-575